Gilead Sciences (GILD) Gross Margin (2009 - 2026)

Gilead Sciences (GILD) has reported Gross Margin for 18 consecutive years, with 79.24% the latest figure, recorded in Q1 2026.

• Gross Margin for Q1 2026 came in at 79.24%, up 234.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 79.35% (up 107.0% YoY), and the FY2025 annual result was 78.83%, up 57.0% from the prior year.
• Gross Margin was 79.24% for Q1 2026 at Gilead Sciences, roughly flat from 79.51% in the prior quarter.
• Over five years, Gross Margin peaked at 81.11% in Q4 2022 and troughed at 70.62% in Q4 2023.
• Average Gross Margin over 5 years is 78.13%, with a median of 78.39% recorded in 2022.
• Year-over-year, Gross Margin soared 1737 bps in 2022 and slumped 1049 bps in 2023.
• Over 5 years, Gross Margin stood at 81.11% in 2022, then dropped by 13 bps to 70.62% in 2023, then advanced by 12 bps to 79.11% in 2024, then gained by 1 bps to 79.51% in 2025, then declined by 0 bps to 79.24% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 79.24% in Q1 2026, 79.51% in Q4 2025, and 79.8% in Q3 2025.